Cargando…

Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha

BACKGROUND: Considerable progress was made by the introduction of interferon to the treatment of chronic hepatitis C virus infection. This treatment, however, is associated with the risk of developing or exacerbating autoimmune diseases, with chronic autoimmune thyroiditis being one of them. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Krupińska, Janina, Urbanowicz, Waldemar, Kaczmarczyk, Mariusz, Kulig, Grzegorz, Sowińska-Przepiera, Elżbieta, Andrysiak-Mamos, Elżbieta, Syrenicz, Anhelli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579705/
https://www.ncbi.nlm.nih.gov/pubmed/23072316
http://dx.doi.org/10.1186/1756-6614-5-10
_version_ 1782260146845515776
author Krupińska, Janina
Urbanowicz, Waldemar
Kaczmarczyk, Mariusz
Kulig, Grzegorz
Sowińska-Przepiera, Elżbieta
Andrysiak-Mamos, Elżbieta
Syrenicz, Anhelli
author_facet Krupińska, Janina
Urbanowicz, Waldemar
Kaczmarczyk, Mariusz
Kulig, Grzegorz
Sowińska-Przepiera, Elżbieta
Andrysiak-Mamos, Elżbieta
Syrenicz, Anhelli
author_sort Krupińska, Janina
collection PubMed
description BACKGROUND: Considerable progress was made by the introduction of interferon to the treatment of chronic hepatitis C virus infection. This treatment, however, is associated with the risk of developing or exacerbating autoimmune diseases, with chronic autoimmune thyroiditis being one of them. The aim of our study was to evaluate the predisposition to autoimmune thyroiditis in patients with chronic hepatitis C virus during IFN-alpha therapy, depending on the presence of polymorphisms in the promoter region of CTLA-4C (−318)T gene and in exon 1 of A49G gene as well as C1858T transition of PTPN22 gene. METHODS: The study was conducted in 149 patients aged between 18 and 70 years (mean of 43.9 years), including 82 men and 67 women. Control group for the assessment of the distribution of analyzed polymorphism of genotypes consisted of 200 neonates, from whom umbilical blood was drawn for the tests. The patients were divided into three groups: group 1 consisted of 114 patients without thyroid impairment before and during IFN-alpha therapy, group 2 contained 9 patients with AT with the onset prior to IFN-alpha treatment, and group 3 comprised 26 patients with AT starting after the beginning of IFN-alpha therapy. RESULTS: The frequency of C1858Tand C(−318)T genotypes observed in the study group did not differ significantly from control group. A significant difference, however, was found for A49G polymorphism. CONCLUSIONS: No association was demonstrated between the occurrence of autoimmune thyroiditis with the onset during IFN-alpha therapy and the presence of polymorphisms within CTLA-4 C(−318)T gene in the promoter region and A49G in exon 1, as well as C1858T transition of PTPN22 gene.
format Online
Article
Text
id pubmed-3579705
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35797052013-02-23 Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha Krupińska, Janina Urbanowicz, Waldemar Kaczmarczyk, Mariusz Kulig, Grzegorz Sowińska-Przepiera, Elżbieta Andrysiak-Mamos, Elżbieta Syrenicz, Anhelli Thyroid Res Research BACKGROUND: Considerable progress was made by the introduction of interferon to the treatment of chronic hepatitis C virus infection. This treatment, however, is associated with the risk of developing or exacerbating autoimmune diseases, with chronic autoimmune thyroiditis being one of them. The aim of our study was to evaluate the predisposition to autoimmune thyroiditis in patients with chronic hepatitis C virus during IFN-alpha therapy, depending on the presence of polymorphisms in the promoter region of CTLA-4C (−318)T gene and in exon 1 of A49G gene as well as C1858T transition of PTPN22 gene. METHODS: The study was conducted in 149 patients aged between 18 and 70 years (mean of 43.9 years), including 82 men and 67 women. Control group for the assessment of the distribution of analyzed polymorphism of genotypes consisted of 200 neonates, from whom umbilical blood was drawn for the tests. The patients were divided into three groups: group 1 consisted of 114 patients without thyroid impairment before and during IFN-alpha therapy, group 2 contained 9 patients with AT with the onset prior to IFN-alpha treatment, and group 3 comprised 26 patients with AT starting after the beginning of IFN-alpha therapy. RESULTS: The frequency of C1858Tand C(−318)T genotypes observed in the study group did not differ significantly from control group. A significant difference, however, was found for A49G polymorphism. CONCLUSIONS: No association was demonstrated between the occurrence of autoimmune thyroiditis with the onset during IFN-alpha therapy and the presence of polymorphisms within CTLA-4 C(−318)T gene in the promoter region and A49G in exon 1, as well as C1858T transition of PTPN22 gene. BioMed Central 2012-10-16 /pmc/articles/PMC3579705/ /pubmed/23072316 http://dx.doi.org/10.1186/1756-6614-5-10 Text en Copyright ©2012 Krupinska et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Krupińska, Janina
Urbanowicz, Waldemar
Kaczmarczyk, Mariusz
Kulig, Grzegorz
Sowińska-Przepiera, Elżbieta
Andrysiak-Mamos, Elżbieta
Syrenicz, Anhelli
Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha
title Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha
title_full Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha
title_fullStr Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha
title_full_unstemmed Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha
title_short Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha
title_sort association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis c treated with interferon alpha
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579705/
https://www.ncbi.nlm.nih.gov/pubmed/23072316
http://dx.doi.org/10.1186/1756-6614-5-10
work_keys_str_mv AT krupinskajanina associationbetweengeneticmutationsandthedevelopmentofautoimmunethyroiditisinpatientswithchronichepatitisctreatedwithinterferonalpha
AT urbanowiczwaldemar associationbetweengeneticmutationsandthedevelopmentofautoimmunethyroiditisinpatientswithchronichepatitisctreatedwithinterferonalpha
AT kaczmarczykmariusz associationbetweengeneticmutationsandthedevelopmentofautoimmunethyroiditisinpatientswithchronichepatitisctreatedwithinterferonalpha
AT kuliggrzegorz associationbetweengeneticmutationsandthedevelopmentofautoimmunethyroiditisinpatientswithchronichepatitisctreatedwithinterferonalpha
AT sowinskaprzepieraelzbieta associationbetweengeneticmutationsandthedevelopmentofautoimmunethyroiditisinpatientswithchronichepatitisctreatedwithinterferonalpha
AT andrysiakmamoselzbieta associationbetweengeneticmutationsandthedevelopmentofautoimmunethyroiditisinpatientswithchronichepatitisctreatedwithinterferonalpha
AT syreniczanhelli associationbetweengeneticmutationsandthedevelopmentofautoimmunethyroiditisinpatientswithchronichepatitisctreatedwithinterferonalpha